FDA Eases Peptide Limits With Backing From RFK Jr.

‘Today, we took long-overdue action to restore science, accountability, and the rule of law,’ the health secretary said.

Health Secretary Robert F. Kennedy Jr. in Washington on Jan. 16, 2026. Madalina Kilroy/The Epoch Times

Federal regulators are going to ease limits on a dozen substances favored by wellness influencers, Health Secretary Robert F. Kennedy Jr. said on April 15.

Regulators will be removing 12 peptides from a list of substances that cannot be manufactured by compounding pharmacies, Kennedy wrote on X. The peptides include BPC-157 and Melanotan II.